Editas Medicine established its headquarters in Cambridge, Massachusetts, on September 2, 2025.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Editas Medicine established its headquarters in Cambridge, Massachusetts, on September 2, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Editas Medicine
discovery-phase pharmaceutical company
Nothing else this week.
-
Cambridge
city in Middlesex County, Massachusetts, United States of America
Related events
- Apnimed has established its company headquarters in Cambridge, MA.
- Biomedix operates from and is headquartered in Cambridge, Massachusetts.
- Obsidian Therapeutics is headquartered in Cambridge, MA, and TD Cowen is providing investment banking coverage for the company.
- Kairos Pharma, Ltd. is headquartered in Cambridge, Massachusetts.
Coverage
Newest first; wire copies grouped- GlobeNewswireEditas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate EDIT-401 achieved ~90% mean LDL-C reduction with single dose in non-human primates EDIT-401 on tra